Fig. 1From: Efficacy and tolerability of the investigational topical cream SD-101 (6% allantoin) in patients with epidermolysis bullosa: a phase 3, randomized, double-blind, vehicle-controlled trial (ESSENCE study)ESSENCE study design. EB epidermolysis bullosa; D day; M month; R randomizationBack to article page